Cipla Set To Launch Favipiravir Drug For Treatment Of COVID Patients

Pharmaceutical firm Cipla is all set to launch Favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process, for the treatment of COVID-19 patients,...

from NDTV News - India-news https://ift.tt/2ORjxma